Analysis of Risk Factors for a Low Immune Response to Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients and Differences Between Second and Third Dose

BACKGROUND: The efficacy of the response to SARS-CoV-2 vaccination in kidney transplant recipients is low. The aim of our study was to evaluate the risk factors correlated with the low antibody response and whether there was an improvement between the second and the third dose. METHODS: A prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Panarese, A., Canossi, A., Fabiani, R., Lupi, D., Maccarone, D., Pace, P., Parzanese, I., Martinez, V., Lancione, L., Savino, V., Cacchioni, C., Cervelli, C., Papola, F., Pisani, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595370/
https://www.ncbi.nlm.nih.gov/pubmed/36400591
http://dx.doi.org/10.1016/j.transproceed.2022.10.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595370/
https://www.ncbi.nlm.nih.gov/pubmed/36400591
http://dx.doi.org/10.1016/j.transproceed.2022.10.032

Ejemplares similares